Download to read offline
![Christmas 2017 – High Value appeal
Cancersarelike
snowflakes,each
oneisunique.
ProfessorHarold
Varm
us
Prostate Cancer UK
Fourth floor
The Counting House
53 Tooley Street
London SE1 2QN
Supporter Care 0300 045 0001
supportercare@prostatecanceruk.org
prostatecanceruk.org
[Month 2017]
Dear [insert name],
The festive season, and the end of the year, is often a time for reflection, and the last couple of
years have certainly given us all plenty to reflect on.
In 2016 we launched not only a new charity strategy, but a new research strategy too, both
outlining how we intended to halve the number of men dying from prostate cancer within ten
years. At that point, we talked about the impact that precision medicine – that is, treatment that’s
tailored based on an individual’s genetic information – would have on prostate cancer survival.
Precision medicine has already transformed the way breast cancer is treated, and experts
around the world predict that it will become the new gold standard for cancer care. In fact, earlier
this summer Dame Sally Davies, England’s Chief Medical Officer, called for genomic testing to
become a routine part of NHS care for people with cancer and rare diseases.
Will you give Ask one to make genomic testing a reality for men with
prostate cancer?
Sadly these advances will come too late for Bernie McDermott, whose daughter Hayley, has
taken this opportunity to thank you personally for your support later on in this pack. But research
we fund now will come in time to make a difference to other men like Bernie and to boys like his
four-year-old grandson, Rory. You can read more about Bernie’s story in the enclosed leaflet.
Your previous generosity means that now, in the run up to the festive season, we can finally
announce funding towards the initial phase of a revolutionary programme of clinical research for
men newly diagnosed with metastatic prostate cancer. This world leading research programme
aims to discover and test new biomarker/treatment combinations in men whose cancer has
not yet become resistant to hormone therapy. The ‘big idea’ behind this research is to find the
genetic changes that drive each man’s cancer and use treatments targeted specifically to those
mutations to destroy them.
Results from the first two arms of the STAMPEDE clinical trial last year and earlier this year
showed very clearly that giving men life-extending treatments like docetaxel or abiraterone
early on, before their cancer becomes resistant to hormone therapy, can help men survive for
years longer.
Similarly, initial results from the TOPARP trial for men whose prostate cancer is resistant to
hormone therapy, and are at a later stage of the disease, were equally positive. This work, led
by Professor Johann de Bono at the Institute of Cancer Research, demonstrated that doctors
could specifically select men who have a mutation in one of the genes responsible for repairing
damaged DNA for treatment. They found that using a drug that targets that genetic change
helps men live significantly longer with what is otherwise a lethal disease.
Continued on next page
[CON ID] [APPEAL CODE] [PACKAGE CODE]
We didn’t talk about his cancer all the time, but I’d havedebriefs with my dad every so often, and he’d give mesnippets of how he was feeling. Dad wasn’t one to go full
on emotional, but we knew he was scared.
Despite that, Dad never Googled his diagnosis or howlong he might be around for. But he did look up theresearch. He just knew that breakthroughs were on theway. He’d say ‘They’re on to something now, Hayley!They’re almost there!’ He knew that research would make
a difference. He said, ‘There’ll be a cure one day. There’ll
be a time when they can stop it. It’s not about me, it won’t
happen in my lifetime, but it’s for Rory.’
At the start of December 2016, Mum and Dad went toEdinburgh. Dad was feeling great, he had a great timeat the Christmas market and then he came back on theFriday in severe pain. He managed a night at home andthen on Saturday, for the first time in the whole of hiscancer journey, I had to call an ambulance.
The doctors said he would definitely come home.Dad wrote me a Christmas list, because he was theChristmas shopper and cooker – that’s how certain wewere. But they were doing a lot of MRI scans while he was
in hospital. Three days later they found that the cancer had
spread everywhere. On Sunday 18 December, he slipped
into a coma, and died on 19 December last year.
My dad would be over the moon about the new researchthat Prostate Cancer UK is funding. Research is vitalto finding out which treatments will suit each man.Every man’s different, and every cancer’s different.My dad used to sit next to a man of the same age in thehospital. He was the same build and had the same typeof cancer, but they’d react completely differently to thetreatments. Despite this they both had to follow the same
pathway. He’d be relieved, I think, for the men out there
who are sons, dads, grandads. To know that there’s anopportunity, a chance. And that’s what you need whenyou’re going up against prostate cancer. You need hope.
Bernie McDermott was, in the words of his daughter
Hayley, a wonderful man. At 59, he had retired asChief Inspector of the West Mercia Police Force, andwas looking forward to enjoying his retirement.Then he was diagnosed with prostate cancer.
“By the time Dad was diagnosed the prostate cancer had
already advanced,” says Hayley. “It was in his prostate,the surrounding tissue, his hips, his spine and his ribs.
He was heartbroken about his diagnosis, and I think itwas the first time I felt that I had to be the grown up,because there was the man, the rock, the centre ofour little family, poorly. It took him a while to accept hisdiagnosis, but then I think he realised that he couldstill choose to carry on, and to live the rest of his life.And that’s what he did.
My fondest childhood memories were of swimmingwith my dad every Sunday; trying to distract him whilehe swam his lengths. But I suppose my most recentmemories are of him with his grandchildren.
When my son Rory was born, Dad was about to startchemotherapy. Mum and Dad were waiting in the hospital
for me. I handed my dad his first grandchild, knowingthat he had prostate cancer and that his time with uswas limited. It was a huge moment. He had the biggestbeaming smile under his moustache as he held Rory forthe first time.
As Rory got older, his relationship with my dad wasexactly what a grandfather – grandson relationship should
be. My dad wasn’t a ‘settle for a handshake’ kind of aman. He wanted Rory to know how much he loved him.And as for Rory, he’d always look out for his Gran-Gran,
as he called him, and when he saw him he’d just sprint
to him.
Two years later, Lydia came along. By that point, it wasvery obvious what direction Dad’s prostate cancer wastaking him in, and I was with my mum and dad every day.
So Lydia was with my dad all the time, and I really thinkshe helped him through those last years.
Bernie’sstory
4696
Donate today to help menwith advanced prostatecancer spend more
Christmases, and makemore precious memories,with the people they love.Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887.
Bernie McDermott10 April 1951 - 19 December 2016
Every45minutes,somewherein the UK, a man dies fromprostate cancer.
This is shocking. But it isn’t inevitable. We are confidentthat with your ongoing support, our new precisionmedicine research programme will help us takesignificant strides towards halving the number of mendying from prostate cancer each year in the UK overthe next ten years.
Part of the reason we’re so confident of the eventualsuccess of this research is the rigorous applicationprocess any research proposal is subject to beforewe decide to fund it. This ensures that we only fundhigh quality, feasible research that represents a goodinvestment and will have a positive impact on the livesof men with and at risk of prostate cancer.
1The research team at Prostate Cancer UK first checkthat the proposal fits within our research strategy, before
sending it off to at least three relevant international experts
for peer review.
2If no serious questions are raised at this stage, theapplication goes on to be assessed by our GrantsAdvisory Panel. These are members of the public whohave been personally affected by prostate cancer,and who volunteer to read the lay summary of eachapplication. The purpose of this panel is to comment onthe importance of the research being proposed to menwith prostate cancer, and the potential impact it couldhave. They also highlight any potential difficulties theresearchers might face in recruiting men to theirclinical trials.
3In the case of this research, the Grants Advisory Panelconcluded that: “The proposal addressed an extremelyimportant issue that would build upon the very promisingSTAMPEDE study.” Our panel concluded that, “Theapplicants made a good case for why this research isneeded, as well as the importance of getting treatment
earlier, and in a more focussed, targeted approach.”
They added that, “Patient and public involvement hadbeen clearly thought through and was considered astrength of the proposal. In particular, the inclusion ofgenetic counselling was considered a good addition.”Furthermore, “The panel had confidence that thetissue collection and patient recruitment would beconducted well.”
4After the Grants Advisory Panel has assessed theproposal, it goes to our expert Research AdvisoryCommittee, where it is again reviewed by experts in thefield before being judged on how fundable it is, and howhighly it should be prioritised for funding.
Ourresearchprogramme
Bernie with
his wife Sue
Bernie with Sue and
their grandchildern
Rory and Lydia
He knew that researchwould make a difference.He said, ‘There’ll be acure one day. There’llbe a time when they
can stop it.’
My dad would be overthe moon about the
new research ProstateCancer UK is funding.Research is vital to findout which treatmentswill suit each man.
Bernie with his
grandson (Rory)
Front page (pg 1)
Pg 5
Page 6
4696 DM Christmas 2017 HV_BOOKLET Z-FOLD_FINAL.indd 2
03/10/2017 12:57](https://image.slidesharecdn.com/brandbreakfast12june2018-prostatecanceruk-180612132023/75/Balancing-direct-marketing-and-brand-in-house-keeping-the-seesaw-level-Brand-and-direct-marketing-Brand-Breakfast-12-June-2018-17-2048.jpg)
Uploaded byCharityComms
Balancing direct marketing and brand in-house: keeping the seesaw level | Brand and direct marketing | Brand Breakfast | 12 June 2018
The document emphasizes the challenges faced by the marketing and communications teams in a charity context, specifically Prostate Cancer UK, due to their disconnection and inefficiencies leading to poorly branded mailings. It highlights personal stories of individuals affected by prostate cancer, the importance of funding research, and the organization's commitment to improving diagnosis and treatment for men. The document outlines strategies and successes in aligning direct marketing efforts with brand identity to better serve the community and secure funding.
More Related Content
Similar to Balancing direct marketing and brand in-house: keeping the seesaw level | Brand and direct marketing | Brand Breakfast | 12 June 2018
Balancing direct marketing and brand in-house: keeping the seesaw level | Brand and direct marketing | Brand Breakfast | 12 June 2018
- 1. Balancing direct marketingand brand in-house: keeping the seesaw level Amy Oberholzer, Head of Individual Giving Philippa Bell, Senior Designer
- 2. INTRODUCTION Amy Oberholzer Head ofIndividual Giving Philippa Bell Senior Designer
- 3. THE CHALLENGE DM andComms teams working as entirely separate entities. Artwork sent to comms team for approval at the 11th hour. Feedback met with reluctance and frustration. 2010
- 4. CODE_LEAF Prostate Cancer UKis a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887. Research has knocked out a cancer I’d been told was going to kill me. Becoming a grandad Cycling John O’Groats to Land’s End Catching that Led Zep reunion tour Surfing Pipeline in Hawaii In 2003, Ian Liston was diagnosed with advanced prostate cancer, which had spread to his bones. Thirteen years and seven clinical trials later, his cancer has been downgraded from a terminal to a chronic illness. “The treatments were experimental, but as I didn’t have any other options, I thought I’d give it a go,” he says. Ian took part in clinical trials of drugs including docetaxel and figitumumab, then abiraterone, followed by olaparib. “By then, all the trials had kept me alive for seven years, meanwhile clinical understanding of a type of radiotherapy had progressed, and doctors thought it could be an option for me. In 2013 I had a 36-day course as part of another trial. The side effects have been difficult but manageable and touch wood, it’s knocked out a cancer that I’d been told was going to kill me in the near future.” Ian is very grateful to still be alive and kicking and he and his wife are making the most of their retirement. After 40 years in the entertainment business (including a role in Star Wars: The Empire Strikes Back), he’s writing his autobiography. Ian’s story shows how much we can achieve in 10 years. Please donate today so we can give more men the best years of their lives. ve just had a CT scan, but I’ve said I on’t want the results until we’re back om our big holiday. My wife retired a ouple of years early so we could spend more time together and she and I are bout to go on a cruise. Columbia, Mexico, finishing in San Francisco – ’s always been on my bucket list. We’re determined to make the best f whatever time we’ve got, with each ther, our children and our grandsons. unding more research is so important ecause prostate cancer really can trike anybody – your father or your rother, even your son (my dad was 67 when I was diagnosed). Only more esearch can protect those men and ive you time to spend together.” We don’t know if I’ve got one year, two years, five years, or somewhere in between. Agencies showed a lack of understanding of the packs: • lacklustre copy • designs that weren’t suited to our brand • time wasted on rewriting and redesigning packs. 2010 Prostate cancer is still one of the biggest killers of men in the UK. Yet diagnosis and treatment is still a decade behind many other cancers. With your help, we’re fighting to change this. The diagnostic test for prostate cancer is unsophisticated, invasive and not always accurate – it’s a process that was developed in 1966. Meanwhile, other cancers can be detected with a relatively simple scan. Thanks to your support, all that could change one day. Research we’re funding through Professor Reyer Zwiggelaar is looking at whether using ultrasound and MRI scans together could lead to a simpler, more accurate diagnosis. Overlaying the two images could give doctors a better image of the prostate, how advanced the cancer is, where it’s located and whether it’s spread. This research is still in its early stages. But one day it could mean more men diagnosed, more accurately – and more lives saved. With you in our corner, we hope to continue investing in this promising area of research. This is just one of 66 exciting research projects that are underway today, thanks to you. You’re in our corner finding answers You’re in our corner leading change The quality of diagnosis and treatment for prostate cancer still varies hugely across the UK. For instance, research has shown that 90% of men in Greater Manchester had their prostate cancer tests fully explained to them in 2012 – while in Dorset only 60% of men did. With you in our corner, we’re fighting to change this. This year we launched the Prostate Cancer UK Quality Checklist – a list of 15 basic standards of care and treatment all men should expect to receive. With your support we’re campaigning hard for full nationwide adoption of the Quality Checklist. We already have the backing of over 200 MPs and MSPs, which has helped lead to the Quality Checklist being used by a growing number of Clinical Commissioning Groups and Health Boards. This is an incredible achievement – and we couldn’t have done it without you. We’re working hard to provide men living with prostate cancer with the information and support they need. With you in our corner, we’re expanding our services out into communities. This year we’ve opened six regional centres in areas where there are gaps in service provision. By working in the heart of communities we can reach more men, raise awareness of prostate cancer and provide vital support. We are also partnering with local organisations to deliver services such as relationship counselling and support groups. We’re excited by the potential of this work to reach more men, and we hope to open three more centres this year. From diagnosis to decision making, from treatment options to living with side-effects, we hope to support men at every stage of their journey. We’ll be able to empower more men with the information they need, to help them take control of their care. And that’s thanks to you. You’re in our corner supporting men Dr.AxelThompson Prostate cancer associated fibroblasts cells under the microscope You may have seen coverage of biomarkers in the media recently and wondered what they are. A biomarker is something that highlights a difference between two biological states, for example the difference between a cancerous cell and a non-cancerous cell, or a cancer cell before and after treatment. The biomarker itself can be anything from a gene, a protein, or a chemical structure, to a part of a cell or molecule. The more biomarkers we can find, and the more we learn about them, the better placed we’ll be to: • Tell exactly which men are at a high risk of prostate cancer. • Diagnose prostate cancer earlier, including whether it’s aggressive or non-aggressive. • Predict how a man’s prostate cancer is likely to respond to treatment. Professor Bevan’s project is a great example of the sort of work we need your help to fund. She has recently secured funding from Prostate Cancer UK to research a specific group of protein biomarkers, known as nuclear receptors. Nuclear receptors are already helping doctors save women with breast cancer. By looking at the levels of these receptors within breast cancer tumours, doctors can predict how aggressive the breast cancer is, and what treatments are most likely to be successful for that particular tumour. We don’t yet have a system like this for classifying prostate tumours, but Professor Bevan believes that because prostate cancer and breast cancer tumours are similar, nuclear receptors could be used in the same way in prostate cancer. The outcomes could be life-changing: • Men with prostate cancer and their doctors would be able to make more informed decisions about their treatment. • Doctors would be able to decide what treatment is likely to work best. • Men with inoperable prostate cancer would live longer, because they’ll get the best treatment first. Help us fund game- changing research into biomarkers Research project: Improving targeted therapy for men with prostate cancer Professor Charlotte Bevan This project has the potential to expand the number of treatment options for prostate cancer. It is at an early stage but we are hopeful it will really make a difference. Professor Charlotte Bevan PSA is the best-known biomarker in prostate cancer If you or someone you know has had prostate cancer, then you will almost definitely have heard of the PSA test. PSA stands for Prostate Specific Antigen. It’s a risk biomarker – if you have a higher than expected level of PSA in your blood, then you’re at an increased risk of having prostate cancer. But it can’t diagnose cancer on its own, so further tests are needed to be sure. Alan’s journey with prostate cancer One of three more familie We’ve just launched a b where we think we can Research into biomarke Better diagnosis Biomarkers will help us find and treat aggressive cancers earlier, and accurately spot the non-aggressive ones, so that men can avoid unnecessary treatments. 1. 2006 Alan is diagnosed with prostate cancer. Casedex lowers his PSA from 189 to 37. 2007 Alan’s PSA starts to rise again. Zoladex injections help to lower it again. 2009 Alan’s first grandchild Lily is born. Alan’s club, Everton FC, come fifth in the league and are FA Cup runners up. 2010 Alan is having major problems peeing. TURP (Trans-Urethral Resection of the Prostate) surgery completely transforms his life; going to the toilet becomes much easier. 2011 Alan’s second grandchild Heather is born. Alan undergoes Radiotherapy. 2012 Alan’s third grandchild Rohan is born, but during the same year his cancer spreads into his lymph nodes and he is diagnosed with advanced prostate cancer. He begins taking abiraterone, with zoledronic acid. This stops the cancer spreading. 2015 Alan’s fourth grandchild Harry is born. Still on abiraterone, Alan’s PSA gets as low as 3, but then begins to creep up again, reaching 7 by October. The doctors gave me 10 more Christmases. This could be my last one. ThisChristmas, 200familieswill loseamantheylove toprostatecancer. Ifundelivered,pleasereturnto:ProstateCancerUK,YorkHouse,WetherbyRoad,LongMarston,YORKYO267NH ProstateCancerUKisaregisteredcharityinEnglandandWales(1005541)andinScotland(SC039332). Registeredcompany02653887. XXXXX_OEXX-XX Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332) Registered company number 2653887 VAT 905 9415 18 WITHYOU INOURCORNER Thanks to you, we are improving research, treatment and support for men with prostate cancer – giving them a fighting chance. Men deserve better. Help us give them the best chance we can. To donate, please call 0845 120 1469, return your donation form or visit prostatecanceruk.org/donate HOWYOU’REFIGHTINGTHECORNERFOR MENWITHPROSTATECANCER Tests, treatments and support for prostate cancer are seriously inadequate. And prostate cancer still kills a father, brother, son, husband or friend every hour of every day. Your support is helping us change this. Here’s how. LT2013022
- 5. In summary, theneeds of the DM team and the brand were out of balance. The result – mailings that weren’t on brand or hitting targets. 2010 BRAND DM TEAM
- 6. TRIAL RUN • Ran workshopsinternally to educate our agencies on our brand, audiences and research • Issues still weren’t resolved, so... • Sought internal sign off to test a pack in-house • Ran a trial pack for our smallest appeal (Autumn) 2016
- 7. AUTUMN 2016 APPEAL By2016, the design team: • Were more involved with the process • Had gained experience and knowledge of mailings • Our two teams had built mutual trust and respect. The result: the design team were invited to pitch designs alongside agency 2016
- 8. As you’re reaching for that‘lifesaving’ glass of red… Mr Adam Sample 22 Sample Street Sample Town Sampleshire SA1 2AS Freepost RTKJ-YBAJ-GKKG Dr Iain Frame Prostate Cancer UK York House Wetherby Road Lond Marston YORKYO26 7NH Pleaseaffix postage stamp hereto help reduce ourcosts. TFDDDAFDFDDAAFDDADAADADTTAADFADAAAAT Prostate Cancer UKFourth FloorThe Counting House53 Tooley StreetLondon SE1 2QN Supporter Care 0300 045 0001 supportercare@prostatecanceruk.org prostatecanceruk.org ...so are we. Increase the value ofyour donation by 25%through Gift AidYes, I am a UK ttre Yes, I’m helping to make the next breakthrough for men with prostate cancer My details: Please amend your details if incorrect. Important: Please tick one of the donation bo Method o Dr Iain Frame Dear Mr Sample,First, I want to say thank you for your support for Prostate Cancer UK so far. As Director of Research, I have a clear overview of both our research funding and the progress we’re making, and that means that I can tell you with absolute certainty that you are making a big difference.Sometimes the idea of relaxing with a nice glass of wine at the end of the day might feel like a lifesaver. But the reality is that the real lifesaver for men with prostate cancer is very different. I love meeting our supporters, and the men with prostate cancer who are right at the heart of our work. It really brings home why we do what we do. But I have to admit that I’ve sometimes found it upsetting to speak to men with advanced disease, who I know won’t be cured. However, the progress we’ve made, thanks to supporters like you, has been enormous. Now I find myself talking to more and more men who’ve been living with advanced prostate cancer for ten years or more, which would have been unthinkable even a few years ago. It’s that sense of seeing a real change that keeps me coming into work each day, and I hope it will also encourage you to keep supporting this important cause, because despite all the new treatment options we now have available, too many men still receive treatments that don’t work for them. This is what keeps me awake at night, trying to find the answers that will enable us to find the right treatment for every man. And with your continued support, I know we can do just that. Mr Adam Sample22 Sample StreetSample TownSampleshireSA1 2AS Mr A Sample, 123 Sample street, Sample town, Sample shire AB12 3DE <CONSTITUENT ID> <APPEAL CODE/PACKAGE CODE> £XX or £XX or £X TFDDDAFDFDDAAFDDADAADADTTAADFADAAAAT It sometimes feels likealifesaver,right? Autumn 2016 appeal
- 9. THE RESULTS Response rate increasedby more than 4%. Average gift went up by just over £4. Return on investment increased by over £7! 2016
- 10. 2016 AND BEYOND Theamazing results meant the time was right to bring the DM appeals fully in-house. However we still had a lot to learn over the next few years. BRAND DM TEAM 2016 2017 2018
- 11. STEPS TO SUCCESS Ourtop tips for creating a winning appeal that balances the needs of both DM and the brand
- 12. 1. CULTIVATE GOODWORKING RELATIONSHIPS • Manage expectations from the start • Communication is key • Test and learn culture 2018
- 13. 1. CULTIVATE GOODWORKING RELATIONSHIPS • Agree timetable/processes that work for all teams 1. DM/Comms/research briefing workshop 2. Design team brainstorm 3. Concept presentation 4. Director approval 5. Pack development 6. Liaise with printers to send print-ready artwork 2018
- 14. 2. ENSURE YOUHAVE THE RIGHT PEOPLE AND SETUP IN-HOUSE • DM, Communications, Design, Research teams all involved • Ensure you have buy-in from senior staff from the very beginning 2018
- 15. 3. RESPECT THEKNOWLEDGE AND EXPERTISE OF EVERYONE INVOLVED 1. Recognise that everyone has different skills and play to their strengths 2. Use audience insight to deliver targeted packs – Standard Value/High Value/Raffle 2018
- 16. Christmas 2017 –Standard Value appeal This Christmas, you could save future generations of men Donatenowand getyourmanof mendecoration. Ifundelivered,pleasereturnto:ProstateCancerUK,YorkHouse,WetherbyRoad,LongMarston,YorkYO267NH ProstateCancerUKisaregisteredcharityinEnglandandWales(1005541)andinScotland(SC039332). Registeredcompany02653887. 4695 13DMAJ17 Postagestamp togohere Freepost RTKJ-YBAJ-GKKG Dr Iain Frame Prostate Cancer UK York House Wetherby Road Lond Marston YORKYO26 7NH Pleaseaffix postage stamp hereto help reduce ourcosts. TFDDDAFDFDDAAFDDADAADADTTAADFADAAAAT Fourth floorThe Counting House53 Tooley StreetLondon SE1 2QN Telephone 030 0045 0001 Fax 020 3310 7107info@prostatecanceruk.org prostatecanceruk.org If this letter reaches you at a difficult time, please accept our sincere apologies for any distress this communication may have caused. It is never our intention to cause any upset. Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). A company registered in England and Wales and limited by guarantee (02653887). VAT 905941518. Registered office: Fourth floor, The Counting House, 53 Tooley Street, London SE1 2QN. Help give men more Christmases with the people who love them. Hayley and Rory share memories of Grandpa Bernie Rory writes a message to Grandpa Bernie to put up on the Christmas tree FOLD Standardvalue-rafflelapsed/lapsing Dear Mr Sample, I’d like to take this opportunity in the run up to the festive season to thank you for taking part in one of our previous raffles, and to let you know you’ve helped to change the way prostate cancer is treated. Your generosity is more important than ever, because every 45 minutes, somewhere in the UK, a man dies from prostate cancer. Someone’s father, brother, uncle, grandfather or friend. Last year, Hayley Yarnley and her four-year-old son Rory spent their first Christmas without Grandpa Bernie.This Christmas, a gift of Ask One can give other men more time with their families. As you’ll read in our enclosed leaflet, Bernie was adamant that research would change the way prostate cancers like his were treated by the time his grandson grew up. And now, thanks to your previous support, we’ve committed funds to the first phase of a revolutionary clinical research programme that will do exactly that. This will change the way men with advanced prostate cancer are treated forever. This is world leading, first of its kind research, that aims to discover and test new biomarker/treatment combinations in men with advanced prostate cancer as soon as they’re diagnosed. This means using each man’s cancer DNA to discover the genetic change that’s driving his particular prostate cancer, and matching it to the treatment that is most likely to halt the disease. Continued overleaf... Mr A Verylongsamplename House name1ANY streetAny townAny shireA12 B34 CONSTITUENT IDAPPEAL CODE PACKAGE CODE TFDDDAFDFDDAAFDDADAADADTTAADFADAAAAT 4695 DM Christmas appeal 2017_LETTER_RLL.indd 1 They’re onto something now, Hayley! They’re almost there… it’s for Rory now. Bernie McDermott, April 1951 - December 2016 4695 DM Christmas appeal 2017_BOOKLET_v6.indd 1 29/09/2017 15:49 Donate now andget your FREE manof men decoration. FREEman of men Christmas decoration
- 17. Christmas 2017 –High Value appeal Cancersarelike snowflakes,each oneisunique. ProfessorHarold Varm us Prostate Cancer UK Fourth floor The Counting House 53 Tooley Street London SE1 2QN Supporter Care 0300 045 0001 supportercare@prostatecanceruk.org prostatecanceruk.org [Month 2017] Dear [insert name], The festive season, and the end of the year, is often a time for reflection, and the last couple of years have certainly given us all plenty to reflect on. In 2016 we launched not only a new charity strategy, but a new research strategy too, both outlining how we intended to halve the number of men dying from prostate cancer within ten years. At that point, we talked about the impact that precision medicine – that is, treatment that’s tailored based on an individual’s genetic information – would have on prostate cancer survival. Precision medicine has already transformed the way breast cancer is treated, and experts around the world predict that it will become the new gold standard for cancer care. In fact, earlier this summer Dame Sally Davies, England’s Chief Medical Officer, called for genomic testing to become a routine part of NHS care for people with cancer and rare diseases. Will you give Ask one to make genomic testing a reality for men with prostate cancer? Sadly these advances will come too late for Bernie McDermott, whose daughter Hayley, has taken this opportunity to thank you personally for your support later on in this pack. But research we fund now will come in time to make a difference to other men like Bernie and to boys like his four-year-old grandson, Rory. You can read more about Bernie’s story in the enclosed leaflet. Your previous generosity means that now, in the run up to the festive season, we can finally announce funding towards the initial phase of a revolutionary programme of clinical research for men newly diagnosed with metastatic prostate cancer. This world leading research programme aims to discover and test new biomarker/treatment combinations in men whose cancer has not yet become resistant to hormone therapy. The ‘big idea’ behind this research is to find the genetic changes that drive each man’s cancer and use treatments targeted specifically to those mutations to destroy them. Results from the first two arms of the STAMPEDE clinical trial last year and earlier this year showed very clearly that giving men life-extending treatments like docetaxel or abiraterone early on, before their cancer becomes resistant to hormone therapy, can help men survive for years longer. Similarly, initial results from the TOPARP trial for men whose prostate cancer is resistant to hormone therapy, and are at a later stage of the disease, were equally positive. This work, led by Professor Johann de Bono at the Institute of Cancer Research, demonstrated that doctors could specifically select men who have a mutation in one of the genes responsible for repairing damaged DNA for treatment. They found that using a drug that targets that genetic change helps men live significantly longer with what is otherwise a lethal disease. Continued on next page [CON ID] [APPEAL CODE] [PACKAGE CODE] We didn’t talk about his cancer all the time, but I’d havedebriefs with my dad every so often, and he’d give mesnippets of how he was feeling. Dad wasn’t one to go full on emotional, but we knew he was scared. Despite that, Dad never Googled his diagnosis or howlong he might be around for. But he did look up theresearch. He just knew that breakthroughs were on theway. He’d say ‘They’re on to something now, Hayley!They’re almost there!’ He knew that research would make a difference. He said, ‘There’ll be a cure one day. There’ll be a time when they can stop it. It’s not about me, it won’t happen in my lifetime, but it’s for Rory.’ At the start of December 2016, Mum and Dad went toEdinburgh. Dad was feeling great, he had a great timeat the Christmas market and then he came back on theFriday in severe pain. He managed a night at home andthen on Saturday, for the first time in the whole of hiscancer journey, I had to call an ambulance. The doctors said he would definitely come home.Dad wrote me a Christmas list, because he was theChristmas shopper and cooker – that’s how certain wewere. But they were doing a lot of MRI scans while he was in hospital. Three days later they found that the cancer had spread everywhere. On Sunday 18 December, he slipped into a coma, and died on 19 December last year. My dad would be over the moon about the new researchthat Prostate Cancer UK is funding. Research is vitalto finding out which treatments will suit each man.Every man’s different, and every cancer’s different.My dad used to sit next to a man of the same age in thehospital. He was the same build and had the same typeof cancer, but they’d react completely differently to thetreatments. Despite this they both had to follow the same pathway. He’d be relieved, I think, for the men out there who are sons, dads, grandads. To know that there’s anopportunity, a chance. And that’s what you need whenyou’re going up against prostate cancer. You need hope. Bernie McDermott was, in the words of his daughter Hayley, a wonderful man. At 59, he had retired asChief Inspector of the West Mercia Police Force, andwas looking forward to enjoying his retirement.Then he was diagnosed with prostate cancer. “By the time Dad was diagnosed the prostate cancer had already advanced,” says Hayley. “It was in his prostate,the surrounding tissue, his hips, his spine and his ribs. He was heartbroken about his diagnosis, and I think itwas the first time I felt that I had to be the grown up,because there was the man, the rock, the centre ofour little family, poorly. It took him a while to accept hisdiagnosis, but then I think he realised that he couldstill choose to carry on, and to live the rest of his life.And that’s what he did. My fondest childhood memories were of swimmingwith my dad every Sunday; trying to distract him whilehe swam his lengths. But I suppose my most recentmemories are of him with his grandchildren. When my son Rory was born, Dad was about to startchemotherapy. Mum and Dad were waiting in the hospital for me. I handed my dad his first grandchild, knowingthat he had prostate cancer and that his time with uswas limited. It was a huge moment. He had the biggestbeaming smile under his moustache as he held Rory forthe first time. As Rory got older, his relationship with my dad wasexactly what a grandfather – grandson relationship should be. My dad wasn’t a ‘settle for a handshake’ kind of aman. He wanted Rory to know how much he loved him.And as for Rory, he’d always look out for his Gran-Gran, as he called him, and when he saw him he’d just sprint to him. Two years later, Lydia came along. By that point, it wasvery obvious what direction Dad’s prostate cancer wastaking him in, and I was with my mum and dad every day. So Lydia was with my dad all the time, and I really thinkshe helped him through those last years. Bernie’sstory 4696 Donate today to help menwith advanced prostatecancer spend more Christmases, and makemore precious memories,with the people they love.Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887. Bernie McDermott10 April 1951 - 19 December 2016 Every45minutes,somewherein the UK, a man dies fromprostate cancer. This is shocking. But it isn’t inevitable. We are confidentthat with your ongoing support, our new precisionmedicine research programme will help us takesignificant strides towards halving the number of mendying from prostate cancer each year in the UK overthe next ten years. Part of the reason we’re so confident of the eventualsuccess of this research is the rigorous applicationprocess any research proposal is subject to beforewe decide to fund it. This ensures that we only fundhigh quality, feasible research that represents a goodinvestment and will have a positive impact on the livesof men with and at risk of prostate cancer. 1The research team at Prostate Cancer UK first checkthat the proposal fits within our research strategy, before sending it off to at least three relevant international experts for peer review. 2If no serious questions are raised at this stage, theapplication goes on to be assessed by our GrantsAdvisory Panel. These are members of the public whohave been personally affected by prostate cancer,and who volunteer to read the lay summary of eachapplication. The purpose of this panel is to comment onthe importance of the research being proposed to menwith prostate cancer, and the potential impact it couldhave. They also highlight any potential difficulties theresearchers might face in recruiting men to theirclinical trials. 3In the case of this research, the Grants Advisory Panelconcluded that: “The proposal addressed an extremelyimportant issue that would build upon the very promisingSTAMPEDE study.” Our panel concluded that, “Theapplicants made a good case for why this research isneeded, as well as the importance of getting treatment earlier, and in a more focussed, targeted approach.” They added that, “Patient and public involvement hadbeen clearly thought through and was considered astrength of the proposal. In particular, the inclusion ofgenetic counselling was considered a good addition.”Furthermore, “The panel had confidence that thetissue collection and patient recruitment would beconducted well.” 4After the Grants Advisory Panel has assessed theproposal, it goes to our expert Research AdvisoryCommittee, where it is again reviewed by experts in thefield before being judged on how fundable it is, and howhighly it should be prioritised for funding. Ourresearchprogramme Bernie with his wife Sue Bernie with Sue and their grandchildern Rory and Lydia He knew that researchwould make a difference.He said, ‘There’ll be acure one day. There’llbe a time when they can stop it.’ My dad would be overthe moon about the new research ProstateCancer UK is funding.Research is vital to findout which treatmentswill suit each man. Bernie with his grandson (Rory) Front page (pg 1) Pg 5 Page 6 4696 DM Christmas 2017 HV_BOOKLET Z-FOLD_FINAL.indd 2 03/10/2017 12:57
- 18. 3. RESPECT THEKNOWLEDGE AND EXPERTISE OF EVERYONE INVOLVED Be flexible with the brand when designing 1. Flex the creative guidelines where required 2. Keep the audience in mind if there are differences of opinion on the artwork 2018
- 19. Please use thesecomplimentary address stickers for a quick and easy entry into the draw. Increase the value of your giftby 25% at no cost to you byopting into Gift Aid below:I am a UK taxpayer and would like Prostate Cancer UK to claim back the tax on this donation and all donations I have made for the four years prior to this date, and all donations I make from the date of t declaration until I I enclose tickets sales totalling £ _I would like to add a donation of £ _Total payment: 1 Spring Raffle 2018 Payment SlipIf any of the following details are incorrect, please amend: YES, I want the chance to win £3,000 and help secure a better future for men! 3rd prize:20 prizes x £50 1st prize: £3,000 2nd prize: £1,000 RAFFLE2018 Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mr A B Sample, Sample Building,123 Sample Street, Sample Area, Sample Locality, Sample TownAB12 3CD Reference numberID XXXXXXXXXXXXXXX Dear SV label name, A win for you and a win for men with prostate cancer! Now that the warmer months are just around the corner for us, why not try your luck again in our Summer Raffle and be in with a chance of winning £3,000 to spend any way you wish! And remember every time you play the raffle you’re helping to change the future for men and their families everywhere. You may already know that prostate cancer is now the third biggest cancer killer in the UK so now even more than ever, we must come together to stop this. To do this we need to move science forward and invest heavily in research, focusing on better diagnosis, better treatment and better prevention. Through this research, we hope to halve the number of expected deaths from prostate cancer by 2026 – that’s over 7,000 lives saved a year. By playing the Summer Raffle, you’ll be contributing to the development of new tests and treatments that can save thousands of lives, all while giving yourself a chance to win £3,000 to spend on yourself, and your loved ones. You could make your holiday dreams a reality, or perhaps find the perfect excuse to splash out on a big celebration with friends, or even make some home improvements. The choice is yours and with the opportunity to win cash prizes your options are endless. To enter you can buy or sell the XX tickets enclosed, all you need to do is pop the ticket stubs in the return envelope enclosed. Or, if you prefer it’s just as easy to enter our Summer Raffle online by visiting raffleentry.org.uk/prostatecancerukTurn the page to find out about our exciting extra Super Seller prize… 123456789 Sampletown AB1 2CD mple Area Sample Locality Sampletown AB1 2CD Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CDMrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD SEED/123456789 S1/012340021668/39800246***** Mr A B Sample Woods Group Bumpers Way Bumpers Farm Chippenham SN14 6NG Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD ampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Sample StreetSample Area Sample Locality Sampletown AB1 2CD Ifundelivered,pleasereturnto:ProstateCancerUK,YorkHouse,WetherbyRoad,LongMarston,YorkYO267NH ProstateCancerUKisaregisteredcharityinEnglandandWales(1005541)andinScotland(SC039332).Registeredcompany02653887. 5109APPEALCODE RAFFLE 2018 A chance to win £3,000 and to help secure a better future for men. EnterourspectacularSummerRaffleforachancetowin 3rdprize:£50 2ndprize:£1,000 Useyour personalised labelhere Achancetowin £3,000 andto helpsecureabetterfutureformen Close date: 28 August 2018 Draw date: 4 Septem ber 2018 £1perticket Pleasedonotdetachcounterfoilsfrom spine ProstateCancerUK SUMMER RAFFLE 2018 Please complete in BLOCK CAPITALS Nam e: Address: Postcode: Telephone: Please return cheques, counterfoils and unsold tickets by 28 August 2018 to: Prostate Cancer UK, Bumpers W ay, Bumpers Farm, Chippenham SN14 6NG RAFFLE2018 3rdprize:£50 2ndprize:£1,000 Enter our spectacular Summer Raffle for a chance to win 3rd prize: £50 2nd prize: £1,000 Summer 2018 raffle – our proposed artwork
- 20. Please use thesecomplimentary address stickers for a quick and easy entry into the draw. Increase the value of your giftby 25% at no cost to you byopting into Gift Aid below:I am a UK taxpayer and would like Prostate Cancer UK to claim back the tax on this donation and all donations I have made for the four years prior to this date, and all donations I make from the date of this declaration until I notify you otherwise.*I am not a UK tax payer, Gift Aid doe apply to me. I enclose tickets sales totalling £ _I would like to add a donation of £ _Total payment: £ _Tick here if you would prefer not to re 1 3 Spring Raffle 2018 Payment SlipIf any of the following details are incorrect, please amend: YES, I want the chance to win £3,000 and help secure a better future for men! 3rd prize:20 prizes x £50 1st prize: £3,000 2nd prize: £1,000 PLAY OUR SPECTACULARSUMMER RAFFLE!A win for you and a win for men with prostate cancer! Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mr A B Sample, Sample Building,123 Sample Street, Sample Area, Sample Locality, Sample TownAB12 3CD Reference numberID XXXXXXXXXXXXXXX 011 Dear SV label name, Now that the warmer months are just around the corner for us, why not try your luck again in our Summer Raffle and be in with a chance of winning £3,000 to spend any way you wish! Remember, every time you play the raffle, you’re helping to secure a better future for men at risk of prostate cancer and their families. You may already know that prostate cancer is now the third biggest cancer killer in the UK so now even more than ever, we must come together to stop this. To do this we need to move science forward and invest heavily in research, focusing on better diagnosis, better treatment and better prevention. Through this research, we hope to halve the number of expected deaths from prostate cancer by 2026 – that’s over 7,000 lives saved a year. By playing the Summer Raffle, you’ll be contributing to the development of new tests and treatments that can save thousands of lives, all while giving yourself a chance to win £3,000 to spend on yourself, and your loved ones. You could make your holiday dreams a reality, or perhaps find the perfect excuse to splash out on a big celebration with friends, or even make some home improvements. The choice is yours and with the opportunity to win cash prizes your options are endless. To enter you can buy or sell the XX tickets enclosed, all you need to do is pop the ticket stubs in the return envelope enclosed. Or, if you prefer it’s just as easy to enter our Summer Raffle online by visiting raffleentry.org.uk/prostatecancerukTurn the page to find out about our exciting extra Super Seller prize… 123456789 mple Area Sample Locality Sampletown AB1 2CD Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CDMrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD SEED/123456789 S1/012340021668/39800246***** Mr A B Sample Woods Group Bumpers Way Bumpers Farm Chippenham SN14 6NG Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Mrs A B SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD SampleSample Building123 Sample StreetSample Area Sample Locality Sampletown AB1 2CD Sampletown AB1 2CD Returnaddress: ProstateCancerUK,YorkHouse,WetherbyRoad,LongMarston,YorkYO267NH ProstateCancerUKisaregisteredcharityinEnglandandWales(1005541)andinScotland(SC039332).Registeredcompany02653887. 510913HMRF18 A chance to win £3,000 and to help secure a better future for men. EnterourspectacularSUMMERRAFFLEforachancetowin SUMMER RAFFLE 2018 3rdprize:20prizesx£50 2ndprize:£1,000 Summer 2018 raffle – final artwork Useyour personalised labelhere Achancetowin £3,000 andtohelpsecureabetterfutureformen Close date: 28 August 2018 Draw date: 4 Septem ber 2018 £1perticket Pleasedonotdetachcounterfoilsfrom spine ProstateCancerUK SUMMER RAFFLE 2018 Please complete in BLOCK CAPITALS Nam e: Address: Postcode: Telephone: Please return cheques, counterfoils and unsold tickets by 28 August 2018 to: Prostate Cancer UK, Bumpers W ay, Bumpers Farm, Chippenham SN14 6NG SPECTACULARSUMMERRAFFLE! 3rdprize:20prizesx£50 2ndprize:£1,000 Enter our spectacular SUMMER RAFFLE for a chance to win 3rd prize: 20 prizes x £50 2nd prize: £1,000
- 21. 3. RESPECT THEKNOWLEDGE AND EXPERTISE OF EVERYONE INVOLVED Be flexible with the brand when designing 3. Think creatively and outside the box 4. White space isn’t always possible! 5. Be honest if an idea isn’t going to work 2018
- 22. Spring 2018 StandardValue appeal FreepostRTKJ-YBAJ-GKKG DrIainFrameProstateCancerUK YorkHouseWetherbyRoadLondMarstonYORK YO267NH Pleaseaffix postagestampheretohelpreduceourcosts.TFDDDAFDFDDAAFDDADAADADTTAADFADAAAAT Dear Personalised,I hope that you’ve had a positive start to the new year and like me, are looking forward to all the good things that 2018 may have in store for us. I’d also like to take this opportunity to say thank you. One thing I’m particularly looking forward to is the start of our latest Research Innovation Awards. To win these Awards, the researchers had to demonstrate how they would take a totally different, never seen before approach to solving the problems facing men with prostate cancer. Much of the research underpinning these Research Innovation Awards wouldn’t have been possible without people like you. Thank you for your continued generosity. You’ve already made a huge difference to the way prostate cancer is diagnosed and treated. But we need your support to keep making a difference. Donations like yours will continue to drive discoveries that take us closer to stopping men dying from prostate cancer. A donation of Ask one could bring life-changing research out of Petri dishes and into patients. I’d like to use the example of Dr Valentine Macaulay at the University of Oxford, one of our Research Innovation Award holders, to show you just what your donations make possible. And to demonstrate why it’s so important that, with your help, we continue to fund early stage research like this. Thanks to your continuing generosity, and that of many others, we’ve funded a number of projects in Dr Macaulay’s laboratory since 2004. All these projects related to a hormone-like protein called Insulin-like Growth Factor 1 (IGF) and its possible role in prostate cancer. What I love about this research is how, when put together, these projects build up a fascinating story of how an initial observation can lead to a new cancer treatment. Prostate Cancer UK Fourth FloorThe Counting House 53 Tooley StreetLondon SE1 2QN We need to catch all prostate cancers while they’re small. You can make a BIG difference. Supporter Care 0300 045 0001 supportercare@prostatecanceruk.org prostatecanceruk.org Dr Valentine Macaulay working in her lab Continued overleaf... Don’t forget, you can increase the value of your donation by 25% at no cost to you by opting into Gift Aid below: Yes, I want to make a BIG difference.My details: Please amend your details if incorrect. Important:Please tick one of the donation boxes below.Method of payment:I enclose a cheque / postal order / CAF charity voucher* made payable to Prostate Cancer UK (*delete where not applicable) OR please debit my: MasterCard / Visa / Solo / Maestro / CAF Card*Card number (Maestro only) Start date / Expiry date / Issue no. Signature(s) of account holder(s): Date: (Maestro only) Please tick as appropriate: I am a UK taxpayer and would like Prostate Cancer UK to claim back the tax on this donation and all donations I have made for the four years prior to this date, and all donations I make from the date of this declaration until I notify you otherwise.* I am not a UK tax payer, Gift Aid does not apply to me. Please note that you cannot Gift Aid any donations made by, or on behalf of a group, company or someone else. Please notify Prostate Cancer UK if you wish to cancel this declaration, change your name or home address, or no longer pay sufficient tax on your Income and/or Capital Gains. *If I have ticked the box headed ‘I am a UK taxpayer’, I confirm I am a UK taxpayer and understand that if I pay less Income Tax and/or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in that tax year it is my responsibility to pay any difference. Please send this completed form to us in the reply envelope enclosed to: Freepost Plus RTKJ-YBAJ-GKKG, Prostate Cancer UK, York House, Wetherby Road, Long Marston, YORK YO26 7NH If you would prefer not to receive an acknowledgement for your gift, tick this box. Mr A SampleHouse name1ANY streetAny townAny shireA12 B34 CONSTITUENT ID APPEAL CODE/PACKAGE CODE TFDDDAFDFDDAAFDDADAADADTTAADFADAAAAT Mr A Sample, 123 Sample street, Sample town, Sample shire AB12 3DE CONSTITUENT ID APPEAL CODE/PACKAGE CODE £XX or £XX or £XX or my choice of £Mailing date I really do hope that my research will make a difference. Dr Valentine Macaulay, University of Oxford. Prostate Cancer UK funded researcher. Helpuscatchprostatecancerbefore it grows too BIG. Small cancers are easier to treat successfully.
- 23. THE RESULTS: OUR SINGLELARGEST DIRECT MAIL PACK – GENERATING OVER 10,000 RESPONSES! Response rate: exceeded target by 14% Average gift increased by £4.15 Return on investment: £13.33 to every £1 we invested 2018
- 24. 4. CELEBRATE SUCCESS!SHARE REGULAR UPDATES ON THE PERFORMANCE OF MAILINGS • Keep teams in the loop with how the packs are performing • Celebrate success – thank everyone involved • Update the charity on successful mailings 2018
- 25. 5. LEARN FROMPREVIOUS APPEALS • Exchange regular feedback through wash-up meetings • Reflect on what went well and be honest about where improvements could be made next time • Feed any learnings into new briefs • Don’t rest on your laurels! Keep striving to learn more about your target audiences and produce even more engaging mailings 2018
- 26. BRAND DM TEAM At ProstateCancer UK, when our DM and comms team are united, we produce our most successful appeals.
- 27. IN SUMMARY: TOP TIPSFOR WORKING TOGETHER 1. Cultivate good working relationships – communication, expectations and timings are key 2. Ensure you have the right people and setup in-house 3. Respect the knowledge and expertise of everyone involved 4. Celebrate success! Share regular updates on the performance of mailings 5. Learn from previous appeals and always look for ways to improve